(Q34508082)

2 August 2017

title

Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors (English)

1 reference

2 August 2017

4

Inge Marie Svane

1 reference

2 August 2017

7

Mads Hald Andersen

1 reference

2 August 2017

6

Per thor Straten

1 reference

2 August 2017

5

Jürgen C Becker

1 reference

2 August 2017

Rikke Sick Andersen

1

1 reference

2 August 2017

Rikke Bæk Sørensen

series ordinal

2

1 reference

2 August 2017

Cathrin Ritter

series ordinal

3

1 reference

2 August 2017

publication date

28 October 2010

1 reference

Cancer Immunology, Immunotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

60

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

227-234

1 reference

Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

The universal character of the tumor-associated antigen survivin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Prospects and challenges of building a cancer vaccine targeting telomerase

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Immunogenicity of Bcl-2 in patients with cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

A listing of human tumor antigens recognized by T cells: March 2004 update

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Reliable prediction of T-cell epitopes using neural networks with novel sequence representations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

SYFPEITHI: database for MHC ligands and peptide motifs

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

A method to quantify binding of unlabeled peptides to class I MHC molecules and detect their allele specificity.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024510

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

7 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0933-Y

Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0933-Y

Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0933-Y

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0933-Y

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

12 December 2020

A sensitive ELISPOT assay to detect low-frequency human T lymphocytes

1 reference

12 December 2020

Mitotic cyclins and cyclin-dependent kinases in melanocytic lesions

1 reference

12 December 2020

Immune selection after antigen-specific immunotherapy of melanoma

1 reference

12 December 2020

T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease

1 reference

12 December 2020

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

1 reference

12 December 2020

10.1007/S00262-010-0933-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference